Unacceptable Principal Diagnosis Codes
ICD-10-CM codes identified as unacceptable when used as principal diagnosis by MCE edit logic.
Source: Definitions of Medicare Code Edits v44.0, edit 9.
Advertisements
Codes on this list
2,666 codes, page 9 of 27.
- T42.2X6SUnderdosing of succinimides and oxazolidinediones, sequela
- T42.3X5AAdverse effect of barbiturates, initial encounter
- T42.3X5DAdverse effect of barbiturates, subsequent encounter
- T42.3X5SAdverse effect of barbiturates, sequela
- T42.3X6AUnderdosing of barbiturates, initial encounter
- T42.3X6DUnderdosing of barbiturates, subsequent encounter
- T42.3X6SUnderdosing of barbiturates, sequela
- T42.4X5AAdverse effect of benzodiazepines, initial encounter
- T42.4X5DAdverse effect of benzodiazepines, subsequent encounter
- T42.4X5SAdverse effect of benzodiazepines, sequela
- T42.4X6AUnderdosing of benzodiazepines, initial encounter
- T42.4X6DUnderdosing of benzodiazepines, subsequent encounter
- T42.4X6SUnderdosing of benzodiazepines, sequela
- T42.5X5AAdverse effect of mixed antiepileptics, initial encounter
- T42.5X5DAdverse effect of mixed antiepileptics, subsequent encounter
- T42.5X5SAdverse effect of mixed antiepileptics, sequela
- T42.5X6AUnderdosing of mixed antiepileptics, initial encounter
- T42.5X6DUnderdosing of mixed antiepileptics, subsequent encounter
- T42.5X6SUnderdosing of mixed antiepileptics, sequela
- T42.6X5AAdverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter
- T42.6X5DAdverse effect of other antiepileptic and sedative-hypnotic drugs, subsequent encounter
- T42.6X5SAdverse effect of other antiepileptic and sedative-hypnotic drugs, sequela
- T42.6X6AUnderdosing of other antiepileptic and sedative-hypnotic drugs, initial encounter
- T42.6X6DUnderdosing of other antiepileptic and sedative-hypnotic drugs, subsequent encounter
- T42.6X6SUnderdosing of other antiepileptic and sedative-hypnotic drugs, sequela
- T42.75XAAdverse effect of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter
- T42.75XDAdverse effect of unspecified antiepileptic and sedative-hypnotic drugs, subsequent encounter
- T42.75XSAdverse effect of unspecified antiepileptic and sedative-hypnotic drugs, sequela
- T42.76XAUnderdosing of unspecified antiepileptic and sedative-hypnotic drugs, initial encounter
- T42.76XDUnderdosing of unspecified antiepileptic and sedative-hypnotic drugs, subsequent encounter
- T42.76XSUnderdosing of unspecified antiepileptic and sedative-hypnotic drugs, sequela
- T42.8X5AAdverse effect of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter
- T42.8X5DAdverse effect of antiparkinsonism drugs and other central muscle-tone depressants, subsequent encounter
- T42.8X5SAdverse effect of antiparkinsonism drugs and other central muscle-tone depressants, sequela
- T42.8X6AUnderdosing of antiparkinsonism drugs and other central muscle-tone depressants, initial encounter
- T42.8X6DUnderdosing of antiparkinsonism drugs and other central muscle-tone depressants, subsequent encounter
- T42.8X6SUnderdosing of antiparkinsonism drugs and other central muscle-tone depressants, sequela
- T43.015AAdverse effect of tricyclic antidepressants, initial encounter
- T43.015DAdverse effect of tricyclic antidepressants, subsequent encounter
- T43.015SAdverse effect of tricyclic antidepressants, sequela
- T43.016AUnderdosing of tricyclic antidepressants, initial encounter
- T43.016DUnderdosing of tricyclic antidepressants, subsequent encounter
- T43.016SUnderdosing of tricyclic antidepressants, sequela
- T43.025AAdverse effect of tetracyclic antidepressants, initial encounter
- T43.025DAdverse effect of tetracyclic antidepressants, subsequent encounter
- T43.025SAdverse effect of tetracyclic antidepressants, sequela
- T43.026AUnderdosing of tetracyclic antidepressants, initial encounter
- T43.026DUnderdosing of tetracyclic antidepressants, subsequent encounter
- T43.026SUnderdosing of tetracyclic antidepressants, sequela
- T43.1X5AAdverse effect of monoamine-oxidase-inhibitor antidepressants, initial encounter
- T43.1X5DAdverse effect of monoamine-oxidase-inhibitor antidepressants, subsequent encounter
- T43.1X5SAdverse effect of monoamine-oxidase-inhibitor antidepressants, sequela
- T43.1X6AUnderdosing of monoamine-oxidase-inhibitor antidepressants, initial encounter
- T43.1X6DUnderdosing of monoamine-oxidase-inhibitor antidepressants, subsequent encounter
- T43.1X6SUnderdosing of monoamine-oxidase-inhibitor antidepressants, sequela
- T43.205AAdverse effect of unspecified antidepressants, initial encounter
- T43.205DAdverse effect of unspecified antidepressants, subsequent encounter
- T43.205SAdverse effect of unspecified antidepressants, sequela
- T43.206AUnderdosing of unspecified antidepressants, initial encounter
- T43.206DUnderdosing of unspecified antidepressants, subsequent encounter
- T43.206SUnderdosing of unspecified antidepressants, sequela
- T43.215AAdverse effect of selective serotonin and norepinephrine reuptake inhibitors, initial encounter
- T43.215DAdverse effect of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounter
- T43.215SAdverse effect of selective serotonin and norepinephrine reuptake inhibitors, sequela
- T43.216AUnderdosing of selective serotonin and norepinephrine reuptake inhibitors, initial encounter
- T43.216DUnderdosing of selective serotonin and norepinephrine reuptake inhibitors, subsequent encounter
- T43.216SUnderdosing of selective serotonin and norepinephrine reuptake inhibitors, sequela
- T43.225AAdverse effect of selective serotonin reuptake inhibitors, initial encounter
- T43.225DAdverse effect of selective serotonin reuptake inhibitors, subsequent encounter
- T43.225SAdverse effect of selective serotonin reuptake inhibitors, sequela
- T43.226AUnderdosing of selective serotonin reuptake inhibitors, initial encounter
- T43.226DUnderdosing of selective serotonin reuptake inhibitors, subsequent encounter
- T43.226SUnderdosing of selective serotonin reuptake inhibitors, sequela
- T43.295AAdverse effect of other antidepressants, initial encounter
- T43.295DAdverse effect of other antidepressants, subsequent encounter
- T43.295SAdverse effect of other antidepressants, sequela
- T43.296AUnderdosing of other antidepressants, initial encounter
- T43.296DUnderdosing of other antidepressants, subsequent encounter
- T43.296SUnderdosing of other antidepressants, sequela
- T43.3X5AAdverse effect of phenothiazine antipsychotics and neuroleptics, initial encounter
- T43.3X5DAdverse effect of phenothiazine antipsychotics and neuroleptics, subsequent encounter
- T43.3X5SAdverse effect of phenothiazine antipsychotics and neuroleptics, sequela
- T43.3X6AUnderdosing of phenothiazine antipsychotics and neuroleptics, initial encounter
- T43.3X6DUnderdosing of phenothiazine antipsychotics and neuroleptics, subsequent encounter
- T43.3X6SUnderdosing of phenothiazine antipsychotics and neuroleptics, sequela
- T43.4X5AAdverse effect of butyrophenone and thiothixene neuroleptics, initial encounter
- T43.4X5DAdverse effect of butyrophenone and thiothixene neuroleptics, subsequent encounter
- T43.4X5SAdverse effect of butyrophenone and thiothixene neuroleptics, sequela
- T43.4X6AUnderdosing of butyrophenone and thiothixene neuroleptics, initial encounter
- T43.4X6DUnderdosing of butyrophenone and thiothixene neuroleptics, subsequent encounter
- T43.4X6SUnderdosing of butyrophenone and thiothixene neuroleptics, sequela
- T43.505AAdverse effect of unspecified antipsychotics and neuroleptics, initial encounter
- T43.505DAdverse effect of unspecified antipsychotics and neuroleptics, subsequent encounter
- T43.505SAdverse effect of unspecified antipsychotics and neuroleptics, sequela
- T43.506AUnderdosing of unspecified antipsychotics and neuroleptics, initial encounter
- T43.506DUnderdosing of unspecified antipsychotics and neuroleptics, subsequent encounter
- T43.506SUnderdosing of unspecified antipsychotics and neuroleptics, sequela
- T43.595AAdverse effect of other antipsychotics and neuroleptics, initial encounter
- T43.595DAdverse effect of other antipsychotics and neuroleptics, subsequent encounter
- T43.595SAdverse effect of other antipsychotics and neuroleptics, sequela